Family History of Ovarian Cancer Linked to Breast Cancer Risk
A team of researchers sought to evaluate familial risks of developing breast cancer among women with a family history of cancers other than breast cancer.
A team of researchers sought to evaluate familial risks of developing breast cancer among women with a family history of cancers other than breast cancer.
Many breast cancer drugs approved in the United States may lack substantial clinical benefit, particularly in the palliative setting.
In the general population, BRCA1, BRCA2, PALB2, and ATM mutations were linked to a significant increased risk of breast cancer.
Estrogen alone and estrogen plus progestin appeared to have “opposite effects” on risk of breast cancer and death among postmenopausal women.